Methods for treating diseases

Some embodiments of the invention include methods for treating an animal for a disease comprising one or more administrations of one or more compositions comprising (a) a TNF signaling inhibitor, (b) a CD40 inhibitor, a FAS signaling inhibitor, or both, and (c) optionally, a caspase 8 inhibitor. Other embodiments include methods for treating the disease comprising one or h more administrations of one or more compositions comprising (a) the TNF signaling inhibitor and (b) the CD40 inhibitor. Certain embodiments include methods for treating the disease comprising one or more administrations of one or more compositions comprising (a) the TNF signaling inhibitor, (b) the FAS signaling inhibitor, and (c) optionally, the caspase 8 inhibitor. Still other embodiments include methods for treating a human for autoimmune disease, T cell mediated autoimmune disease, IL-1β mediated autoimmune disease, or cytokine release syndrome. Additional embodiments of the invention are also discussed herein.

Psychedelics for treatment of pain

A method of treating pain, by administering an effective amount of a psychedelic to an individual and treating pain in the individual. A method of treating a pain syndrome, by administering an effective amount of a psychedelic to an individual, and providing a central effect, an effect on depression, and an inflammatory effect.

Movement disorders

A method of treating movement disorders, by administering an effective amount of a psychedelic to an individual having a movement disorder, and treating the movement disorder.

Lsd salt crystal forms

Polymorphic forms of lysergic acid diethyl amide (LSD) in crystalline salt forms. A pharmaceutical formulation of polymorphic forms of LSD in crystalline salt forms including pharmaceutically acceptable excipients. Polymorphic forms of LSD free-base. Polymorphic forms of a salt form of LSD.

Controlling effects after 5ht2a agonists administration

Methods of psychotherapy and drug combinations involving administration of a psychedelic like LSD in conjunction with a “duration shortening agent” that reduces the acute effects and duration of the psychedelic trip

Psychedelics for treatment of pain

A method of treating pain, by administering an effective amount of a psychedelic to an individual and treating pain in the individual.

LSD dose identification

Methods of dosing psychedelics at “microdose, minidose, psychedelic dose, good effect dose, ego-dissolution dose, or cardiovascular safe dose,” and “producing maximum positive subjective acute effects” “associated with more positive long-term outcomes and minimizing negative acute effects.”

Movement disorders

A method of treating movement disorders, by administering an effective amount of a psychedelic to an individual having a movement disorder, and treating the movement disorder.

>